Skip to main content
NCBI home page
Journal of Cancer Research and Clinical Oncology logoLink to Journal of Cancer Research and Clinical Oncology
. 1997 Dec;123(9):514–521. doi: 10.1007/BF01192207

Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer

Gerald G Wulf 1,✉, Britta Jürgens 1, Torsten Liersch 2, Wolfgang Gatzemeier 2, Helmut Rauschecker 2, Christian Buske 1, Michael Hüfner 1, Wolfgang Hiddemann 1, Bernhard Wörmann 1
PMCID: PMC12201417  PMID: 9341902

Abstract

Tumor cell dissemination in the bone marrow is an independent prognostic marker for relapse and survival for patients with primary breast cancer. Parathyroid-hormone-related protein (PTHrP) is expressed in most primary tumors and bone metastases of patients with breast cancer. PTHrP acts as an autocrine growth factor for breast cancer cells in vitro and there is evidence that it is especially important for osseous metastasis. For a sensitive detection of PTHrP-positive disseminated tumor cells a reverse transcriptase/polymerase chain reaction (RT/PCR) assay for PTHrP transcripts in the peripheral blood (PB) and in the bone marrow (BM) has been established. In mixing studies, the sensitivity of the reverse transcriptase/polymerase chain reaction (RT/PCR) for PTHrP was one tumor cell in 1×106 mononuclear cells. At this level of sensitivity, transcripts of PTHrP were detected in none of 30 PB samples and in 3 of 25 BM samples of healthy volunteers: there were also no transcripts of PTHrP in the PB and BM of 6 patients with benign breast lesions. The PB samples of 31 patients and the BM samples of 34 patients with predominantly early-stage breast cancer were tested for PTHrP expression along with immunocytology against cytokeratin 18 (CK18) as a standard immunological detection technique. PTHrP expression was shown in 9 of 31 patients in the PB and in 9 of 34 patients in the BM. In 30 patients, PB and BM samples were available simultaneously. There were cases of combined positive findings in the PB and the BM (4/30) and of isolated positivity in the PB (5/30) or in the BM (4/30). Compared to immunocytology, RT/PCR assay of PTHrP assay was significantly more sensitive in the peripheral blood (8/30 by RT/PCR compared to 1/30 by immunocytology). In the bone marrow there were cases of positivity for both markers (2/34), cases of isolated positivity by immunocytology for CK18 (3/34) and cases of isolated positivity for PTHrP transcripts (7/34). In conclusion the RT/PCR assay for PTHrP transcripts is a feasible and very sensitive technique for the detection of tumor cell dissemination in the PB, even in patients with early-stage breast cancer. The specificity of detection of PTHrP transcripts in the bone marrow is limited, possibly because of autochthonous expression of PTHrP in osteoblastic cells. The clinical follow-up of the subgroups of patients at risk, as defined by this assay, will show its prognostic significance for patients with breast cancer.

Key words: RT/PCR, PTHrP, Metastasis, Blood, Bone marrow, breast cancer

Abbreviations

RT/PCR

reverse transcriptase/polymerase chain reaction

PTHrP

parathyroid-hormone-related protein

BM

bone marrow

PB

peripheral blood

MNC

mononuclear cells

CK18

cytokeratin 18

References

  1. Asa SL, Henderson J, Goltzman D, Drucker DJ (1989) Parathyroid hormone-like peptide in normal and neoplastic human endocrine tissues. J Clin Endocrin Metabol 71:1112–1118 [DOI] [PubMed] [Google Scholar]
  2. Aubin JE, Liu F, Malaval L, Gupta AK (1995) Osteoblast and chondroblast differentiation. Bone 17:77S-83S [DOI] [PubMed] [Google Scholar]
  3. Birch MA, Carron JA, Scott M, Fraser WD, Gallagher JA (1995) Parathyroid hormone (PTH)/PTH-related protein (PTHrP) receptor expression and mitogenic responses in human breast cancer cell lines. Br J Cancer 72:90–95 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bouizar Z, Spyratos F, Deytieux S, Vernejoul MC de, Jullienne A (1993) Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases. Cancer Res 53:5076–5078 [PubMed] [Google Scholar]
  5. Boyum A (1964) Separation of white blood cells. Nature 204:793–810 [DOI] [PubMed] [Google Scholar]
  6. Brossart P, Schmier J-W, Krüger S, Willhauck M, Scheibenbogen C, Möhler T, Keilholz U (1995) A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res 55:4065–4068 [PubMed] [Google Scholar]
  7. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L (1994) Mobilization of tumor cells and hematopoetic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636–640 [PubMed] [Google Scholar]
  8. Choy A, McCulloch P (1996) Induction of tumour cell shedding into effluent venous blood breast cancer surgery. Br J Cancer Res 73:79–82 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY (1984) Immunenzymatic labeling of monoclonal antibodies using immunecomplexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP) complexes. J Histochem Cytochem 32:219–229 [DOI] [PubMed] [Google Scholar]
  10. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS (1994) Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Onc 12:475–482 [DOI] [PubMed] [Google Scholar]
  11. Dearnaley DP, Ormerod MG, Sloane JP (1991) Micrometastases in breast cancer: long-term follow-up of the first patient cohort. Eur J Cancer 27:236–239 [DOI] [PubMed] [Google Scholar]
  12. Deguchi T, Doi T, Ehara H, Ito S, Takahashi Y, Nishimo Y, Fujihiro S, Kawamura T, Komeda H, Horie M (1993) Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 53:5350–5354 [PubMed] [Google Scholar]
  13. Diel IJ, Kaufmann M, Görner R, Costa SD, Kaul S, Bastert G (1992) Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol 10:1534 [DOI] [PubMed] [Google Scholar]
  14. Fields K, Moscinski L, Trudeau W, Elfenbein G (1994) The use of polymerase chain reaction for amplification of cytokeratin 19 to detect bone marrow micrometastasis in breast cancer. Proc Am Soc Clin Oncol 13:115 [Google Scholar]
  15. Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M (1994) Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 12:725 [DOI] [PubMed] [Google Scholar]
  16. Harbeck N, Untch M, Pache L, Eiermann W (1994) Tumor cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br J Cancer 69:566–571 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Health DA, Senior PV, Varley JM, Beck F (1990) Parathyroid-hormone-related protein in tumors associated with hyper calcemia. Lancet 335:66–69 [DOI] [PubMed] [Google Scholar]
  18. Iguchi H, Tanaka S, Ozawa, Y, Kashiwakuma T, Kimura T, Higara T, Ozawa H, Kono A (1996) A role of PTHrP in the process of bone metastasis. Proc Am Assoc Cancer Res 37:89 [PubMed] [Google Scholar]
  19. Jauch KW, Friess S, Grützner U, Heiss MM, Funke I (1995) Prognostic significance of “micrometastases”. Onkologie 18:525–532 [Google Scholar]
  20. Krismann M, Todt B, Schröder J (1995) Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol 13:2769–2775 [DOI] [PubMed] [Google Scholar]
  21. Krüger W, Krizizanowski, Holweg M, Stockschläger M, Kröger N, Jung R, Mross K, Jonat W, Zander A (1996) Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients. J Cancer Res Clin Oncol 122:679–686 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lehrer S, Terk M, Piccoli SP, Song HK, Lavagnini P, Luderer AA (1996) Reverse transcriptase-polymerase chain reaction for prostate specific antigen may be a prognostic indicator in breast cancer. Br J Cancer 74:871–873 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Liapis H, Crouch EC, Grosso LE, Kitazawa S, Wick MR (1993) Expression of parathyroidlike protein in normal, proliferative and neoplastic human breast tissues. Am J Pathol 143:1169–1178 [PMC free article] [PubMed] [Google Scholar]
  24. Mangin M, Ikeda K, Dreyer BE, Broadus AE (1989) Isolation and characterization of the human parathyroid hormone-like peptide gene. Proc Natl Acad Sci USA 86:2408–2412 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mansi J, Berger U, Easton D, McDonnell T, Redding WH, Gazet J-C, McKinna A, Powles TJ, Coombes RC (1987) Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J 295:1093–1096 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Martin TJ, Allan EH, Caple IW, Care AD, Danks JA, Diefenbach-Jagger H, Ebeling PR, Gillespie MT, Hammonds G, Heath JA, Hudson PJ, Kemp BE, Kubota M, Kukreja SC, Moseley JM, Ng KW, Raisz LG, Rodda CP, Simmons HA, Suva LJ, Wettenhall REH, Wood WI (1989) Parathyroid hormone-like Protein: Isolation, molecular cloning and mechanism of action. Recent Prog Horm Res 45:467–502 [DOI] [PubMed] [Google Scholar]
  27. McGrew EA (1965) Criteria for the recognition of malignant cells in circulating blood. Acta Cytol 9:58 [PubMed] [Google Scholar]
  28. Melchior S, Corey E, Ellis W, Ross A, Layton T, Arfman E, Oswin M, Lange P, Vessella R (1996) Highly sensitive reverse transcriptase polymerase chain reaction (RT-PCR) assay for prostate specific antigen (PSA) messenger RNA detects early tumor spread in patients with clinically localized prostate cancer (CaP). Proc Am Assoc Cancer Res 37:89 [Google Scholar]
  29. Moniz C, Burton PBJ, Malik AN, Dixit M, Banga JP, Nicolaides K, Quirle P, Knight DE, McGregor AM (1990) Parathyroid hormone-related peptide in normal human fetal development. J Mol Endocrinol 5:259–266 [DOI] [PubMed] [Google Scholar]
  30. Moseley JM, Kubota M, Diefenbach-Jagger H, Wettenhall REH, Kemp BE, Suva LJ, Rodda CP, Ebeling PR, Hudson PJ, Zajac JD, Martin TJ (1987) Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci USA 84:5048–5052 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Moseley JM, Hayman JA, Danks JA, Alcorn D, Grill V, Southby J, Horton MA (1991) Immunhistochemical detection of parathyroid hormone-related protein in human fetal epithelia. J Clin Endocrinol Metab 73:478–484 [DOI] [PubMed] [Google Scholar]
  32. Moss TJ, Ross AA (1992) The risk of tumor cell contamination in peripheral blood stem cell collections. J Hematoth 1:225–232 [DOI] [PubMed] [Google Scholar]
  33. Nagy KP (1965) A study of normal, atypical, and neoplastic cells in the white cell concentrate of the peripheral blood. Acta Cytol 9:61 [PubMed] [Google Scholar]
  34. Naito H, Kuzumaki N, Uchino J, Kobayashi R et al (1991) Detection of tyrosine hydroxylase mRNA and minimal neuro-blastoma cells by the reverse transcription-polymerase chain reaction. Eur J Cancer 27:762–765 [DOI] [PubMed] [Google Scholar]
  35. Osborne MP, Wong GY, Asina S, Old LJ, Cote RJ, Rosen PP (1991) Sensitivity of immuncytochemical detection of breast cancer cells in human bone marrow. Cancer Res 51:2706–2709 [PubMed] [Google Scholar]
  36. Pantel K (1996) Detection of minimal disease in patients with solid tumors. J Hematother (in press) [DOI] [PubMed]
  37. Pantel K, Schlimok G, Angstwurm M, Weckermann D, Schmaus W, Gath H, Passlick B, Izbicki JR, Riethmüller G (1994) Methodological analysis of immuncytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematoth 3:165–173 [DOI] [PubMed] [Google Scholar]
  38. Porro G, Menard S, Tagliabue E, Orefice S, Salvadori B, Squicciarini P, Andreola S, Rilke F, Colnaghi MI (1988) Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients. Cancer 61:2405–2411 [DOI] [PubMed] [Google Scholar]
  39. Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, Bennett RC, Martin TJ (1991) Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res 51:3059–3061 [PubMed] [Google Scholar]
  40. Redding WH, Coombes RC, Monaghan P, Clink H, Imrie SF, Dearnaley DP, Ormerod ME, Sloane JP, Gazet JC, Powles TJ (1983) Detection of micrometastases in patients with primary breast cancer. Lancet II:1271–1274 [DOI] [PubMed] [Google Scholar]
  41. Ross AA, Cooper BW, Lazarus HM, et al (1993) Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82:2605–2610 [PubMed] [Google Scholar]
  42. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491 [DOI] [PubMed] [Google Scholar]
  43. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463–5467 [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Schlimok G, Funke I, Holzmann B, Göttinger HG, Schmidt G, Häuser H, Swierkot S, Warnecke HH, Schneider B, Koprowski H, Riethmüller G (1987) Micrometastatic cancer cells in the bone marrow: In vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc Natl Acad Sci USA 84:8672–8676 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Schönfeld A, Luqmani Y, Smith D, O'Reiely S, et al (1994) Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54:2986–2990 [PubMed] [Google Scholar]
  46. Southby J, Kissin MW, Danks JA, Hayman JA, Moseley JM, Henderson MA, Bennett RC, Martin TJ (1990) Immunhistochemical localization of parathyroid hormone-related protein in human breast cancer. Cancer Res 59:7710–7716 [PubMed] [Google Scholar]
  47. Suda N, Gillespie MT, Traianedes K, Zhou H, Ho PWM, Hards DK, Allan EH, Martin TJ, Moseley JM (1996) Expression of parathyroid hormone-related protein in cells of osteoblast lineage. J Cell Physiol 166:96–104 [DOI] [PubMed] [Google Scholar]
  48. Weiss L (1990) Metastatic inefficiency. Adv Cancer Res 54:159–211 [DOI] [PubMed] [Google Scholar]

Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES